Abbott Laboratories is unveiling a coronavirus test that can tell if someone is infected in as little as five minutes, and is so small and portable it can be used in almost any health-care setting.
The medical-device maker plans to supply 50,000 tests a day starting April 1, said John Frels, vice president of research and development at Abbott Diagnostics. The molecular test looks for fragments of the coronavirus genome, which can quickly be detected when present at high levels. A thorough search to definitively rule out an infection can take up to 13 minutes, he said.
Abbott has received emergency use authorisation from the US Food and Drug Administration “for use by authorised laboratories and patient care settings,” the company said on Friday.
Bu hikaye Business Standard dergisinin March 29, 2020 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Business Standard dergisinin March 29, 2020 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
KEEPING UP WITH BRAZIL
If India wants to become a biofuel superpower like Brazil, it needs to get its ethanol 2.0 policies right
Indian cities reduce PM2.5 levels by 27% in 6 yrs: Report
Indian cities achieved an average 27 per cent reduction in PM2.5 pollution levels from 2019 to 2024, with those under NCAP alone recording a 24 per cent decline, a new report has found.
India adding N-power faster than global peers
India's nuclear power generation has grown twice as fast as the rest of the world in recent times.
Manmohan Singh was unfailingly measured, thoughtful and wise
It is both an honour and pleasure to have been invited to address this event in honour of Dr Manmohan Singh, the greatest man I have had the privilege of knowing.
Compare cited reasons with policy terms before challenging decision
Health and general insurers paid 82 per cent of claims by volume and 71.3 per cent by value (₹1.17 crore), according to the Insurance Regulatory and Development Authority of India's (Irdai's) annual report for 2023-24.
PVR Inox shares fade to black: Down 23%
Shares hit 44-month low as HMPV scare rattles market
Indo Farm shares up 27% on mkt debut
Shares of Indo Farm Equipment on Tuesday ended with a premium of over 27 per cent against the issue price of ₹215. The stock started the trade at ₹258.40, reflecting a premium of 20.18 per cent on the BSE. During the day, it jumped 33.44 per cent to ₹286.90. Shares of the firm ended at ₹272.70, up 26.83 per cent. At the NSE, it listed at ₹256, up 19 per cent. The stock ended at ₹273.69, a gain of 27.29 per cent. The company's market valuation stood at ₹1,310.37 crore.
Zomato shares fall 5% after Jefferies downgrade
Food aggregator Zomato's shares bled on Tuesday, as the stock plunged up to 5 per cent to hit an intraday low of ₹251.40 per share.
Q3 updates point to strong growth ahead for jewellery companies
Two leading listed jewellers, Titan and Kalyan, have just released their pre-quarterly updates for the third quarter of the current financial year (Q3FY25).
Equities may deliver 8-12% in 2025, says ABSL MF
In a year that is poised to be one of macroeconomic turbulence, with significant policy shifts and global trade uncertainties, investors should consider asset allocation strategies to capitalize on gains in all asset classes while reducing risks, Aditya Birla Sun Life Mutual Fund (ABSL MF) said in its outlook for 2025.
